Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis
Purpose
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Condition
- Open-Angle Glaucoma
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data - have Glaucoma
Exclusion Criteria
- Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies. - Patients with refractory CME or CME persisting 3 months or more post-operatively - Patients with incomplete IOP, medication logs or VF data within post-operative period - Prior incisional surgery or MIGS
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Retrospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Single Group/Cohort retrospectively utilized | This will be 300 eyes that have undergone the combination of Phacoemulsification, OMNI Canaloplasty and Hydrus microstent that will successfully lower IOP in ethnically-diverse patients with Open Angle Glaucoma |
|
Recruiting Locations
Barnet Dulaney Perkins Eye Center
Mesa, Arizona 85206
Mesa, Arizona 85206
More Details
- NCT ID
- NCT06953349
- Status
- Recruiting
- Sponsor
- Barnet Dulaney Perkins Eye Centers
Detailed Description
The use of combination Phacoemulsification, OMNI Canaloplasty and Hydrus microstent successfully lowers IOP in ethnically-diverse patients with Open Angle Glaucoma